Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (2254)	8/31/1998 5:02:00 PM
From: Scott H. Davis	Respond to of 4676

Miljenko & All - That caught my eye too. Is there a good precedent and an established process for the FDA to re-consider an item as a first-line therapy when additional safty/efficacy data is availible? Curious, Scott Others wondered about how to play this. Remember market scares are oft associated with "flight to cash/quality" herd stampedes. When people get some guts back, it will probably also be large caps/value plays. The biotech sector was already in bad shape before the recent plunge. While buying at this level might make sense for a long term hold, waiting more to re-enter may yield more shares for your long term $s. IMSCO Scott